Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial

著者: José Baselga, Ian Bradbury, Holger Eidtmann, Serena Di Cosimo, Evandro de Azambuja, Claudia Aura, Henry Gómez, Phuong Dinh, Karine Fauria, Veerle Van Dooren, Gursel Aktan, Aron Goldhirsch, Tsai-Wang Chang, Zsolt Horváth, M.A. Coccia-Portugal, Julien Dômont, Ling-Min Tseng, Georg Kunz, Joohyuk Sohn, Semiglazov Vf, Guillermo Lerzo, Markéta Palácová, Volodymyr Probachai, Lajos Pusztai, Michael Untch, Richard D. Gelber, Martine Piccart - The Lancet 2012 被引用: 1,314